On Invalid Date, Eledon Pharmaceuticals (NASDAQ: ELDN) reported Q4 2023 earnings per share (EPS) of -$0.29, up 92.91% year over year. Total Eledon Pharmaceuticals earnings for the quarter were -$9.63 million. In the same quarter last year, Eledon Pharmaceuticals's earnings per share (EPS) was -$4.09.
As of Q2 2024, Eledon Pharmaceuticals's earnings has grown year over year. Eledon Pharmaceuticals's earnings in the past year totalled -$40.33 million.
What is ELDN's earnings date?
Eledon Pharmaceuticals's earnings date is Invalid Date. Add ELDN to your watchlist to be reminded of ELDN's next earnings announcement.
What was ELDN's revenue last quarter?
On Invalid Date, Eledon Pharmaceuticals (NASDAQ: ELDN) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Eledon Pharmaceuticals's revenue was $0.00.
What was ELDN's revenue growth in the past year?
As of Q2 2024, Eledon Pharmaceuticals's revenue has grown null year over year. Eledon Pharmaceuticals's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.